Skip to main content
Caplight Logo









DifGen Pharmaceuticals

DifGen Pharmaceuticals

Private
Miramar, FloridaHealthcare & Life Scienceshttps://difgen.com/

Company Overview

DifGen Pharmaceuticals is a pharmaceutical company that specializes in the development and manufacturing of complex, high-barrier-to-entry generic and specialty pharmaceutical products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

generic pharmaceuticalscomplex injectablesCDMOcontract development and manufacturingANDAabbreviated new drug applicationgeneric drug manufacturersterile productssolid oral dosagepharmaceutical supply chainwhite label pharmaaffordable medicationpharma outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DifGen Pharmaceuticals Comparables

Compare DifGen Pharmaceuticals with similar companies based on industry and business-model similarity.

DifGen Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cosette Pharmaceuticals, Inc.
81%
Aurobindo Pharma Limited
81%
Dr. Reddy's Laboratories
74%

DifGen Pharmaceuticals Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Ramandeep Singh Jaj

Founder & Co-CEO

Founding Team

Santhanakrishnan Srinivasan

Founder and Co-CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2025

    Grew 16% QoQ, from 115 to 133 employees.

  • Mar 9, 2025

    Grew 21% QoQ, from 105 to 127 employees.

DifGen Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

DifGen Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DifGen Pharmaceuticals's valuation, stock price, and market status.

Is DifGen Pharmaceuticals a public or private company?

DifGen Pharmaceuticals is a private company.

What is the current stock price of DifGen Pharmaceuticals?

DifGen Pharmaceuticals is a private company with no public stock price. Caplight tracks DifGen Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is DifGen Pharmaceuticals worth (valuation)?

Valuation information for DifGen Pharmaceuticals is not publicly available.

Can I buy DifGen Pharmaceuticals stock?

DifGen Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DifGen Pharmaceuticals's last funding round?

Funding round information for DifGen Pharmaceuticals is not publicly available.

Who are the main investors in DifGen Pharmaceuticals?

Investor information for DifGen Pharmaceuticals is not publicly disclosed.

Will DifGen Pharmaceuticals IPO soon?

No public IPO plans have been announced for DifGen Pharmaceuticals.

How can I track DifGen Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DifGen Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMiramar, Florida
Employee Range175
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?